Proprotein convertase subtilisin/kexin type 9 inhibitors treatment in dyslipidemic patients: a real world prescription.
Derosa G, Maffioli P, D'Angelo A, Girola A, Colombo E, Fiorenza AM, Macias JJC, Sanchez CL, Raddino R, Pasini GF, Triggiani M, Maresca AM, Tandurella N, Guasti L.
Derosa G, et al. Among authors: guasti l.
J Cardiovasc Med (Hagerstown). 2022 Feb 1;23(2):91-97. doi: 10.2459/JCM.0000000000001237.
J Cardiovasc Med (Hagerstown). 2022.
PMID: 34690259